Medicine and Dentistry
Cohort Analysis
65%
Randomized Controlled Trial
55%
Patient with Type 2 Diabetes
46%
COVID-19
45%
Congenital Diaphragm Hernia
43%
Silo-Filler's Disease
43%
Quality of Life
41%
Tofogliflozin
39%
Retrospective Cohort Study
37%
Disease
35%
Maturity Onset Diabetes of the Young
35%
Mycobacterium Avium Complex
34%
Cardiovascular Disease
33%
Hazard Ratio
29%
Adverse Event
27%
Hemoglobin A1c
27%
Cross Sectional Study
26%
Diseases
26%
Brain Metastasis
26%
Anterior Chamber of Eyeball
26%
Aortic Dissection
26%
Surgical Infection
26%
Olanexidine
26%
Coronavirinae
26%
Dry Eye
26%
Tear Film
26%
Eye Disease
24%
Body Mass Index
23%
Prevalence
23%
Observational Study
22%
Group Therapy
21%
Diabetes Mellitus
21%
Endovascular Aneurysm Repair
20%
Atherosclerosis
20%
Symptom
20%
Clinical Feature
20%
Hemodialysis
20%
Telemedicine
20%
Overall Survival
19%
COVID-19 Vaccination
19%
Infection
19%
Prospective Study
19%
Graft Versus Host Reaction
19%
Odds Ratio
19%
Clinical Trial
18%
Disease Exacerbation
18%
Small Cell Lung Cancer
17%
Stereotactic Radiosurgery
17%
Post-Hoc Analysis
17%
Iliac Artery
17%
Sitagliptin
17%
Prognostic Assessment
17%
Controlled Clinical Trial
17%
Chlorhexidine
17%
Chronic Inflammatory Demyelinating Polyneuropathy
17%
Stomach Cancer
17%
Diethylstilbestrol
17%
Esophageal Squamous Cell Carcinoma
17%
Diagnosis
16%
Diabetes
15%
Limb
15%
Combination Therapy
14%
Neoplasm
14%
Arm
14%
Optical Coherence Tomography
13%
Cardiovascular System
13%
Sodium Glucose Cotransporter 2 Inhibitor
13%
Artificial Respiration
13%
Intima-Media Thickness
13%
Elderly Patient
13%
Advanced Cancer
13%
Progression Free Survival
12%
Malignant Neoplasm
12%
Lung Cancer
12%
Drug Therapy
12%
Obsessive Compulsive Disorder
11%
Systolic Blood Pressure
11%
Recurrence Free Survival
11%
Glycon
11%
Dyspnea
11%
Obstructive Sleep Apnea
10%
Sequela
10%
Asthma
10%
Health Care Cost
10%
Extubation
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Vasculotropin
10%
Chronic Kidney Disease
10%
Preventive Medicine
10%
Glomerular Filtration Rate
10%
Scoring System
10%
Postoperative Complication
10%
Insulin Resistance
10%
Politef
10%
Kidney Function
9%
Drug Megadose
9%
General Anesthesia
9%
Blood Pressure
9%
Chronic Obstructive Pulmonary Disease
9%
Glycemic
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Coronavirinae
60%
Non Insulin Dependent Diabetes Mellitus
55%
Disease
51%
Tofogliflozin
48%
Chronic Obstructive Lung Disease
36%
Diseases
35%
Cardiovascular Disease
34%
Disease Exacerbation
33%
Clinical Trial
28%
Brain Metastasis
26%
Hemodialysis
26%
Congenital Diaphragm Hernia
26%
Hemoglobin A1c
26%
Symptom
25%
Clinical Feature
25%
Overall Survival
23%
Adverse Event
22%
Atherosclerosis
21%
Prospective Cohort Study
20%
Lung Disease
19%
Diabetes Mellitus
19%
Progression Free Survival
18%
Aortic Dissection
17%
Chronic Kidney Failure
17%
Syndrome
17%
Methotrexate
17%
Rheumatoid Arthritis
17%
Chronic Thromboembolic Pulmonary Hypertension
17%
Vaccination Policy
17%
Chemotherapy
17%
Esophageal Squamous Cell Carcinoma
17%
Denosumab
17%
Hypocalcaemia
17%
Infection
16%
SARS Coronavirus
16%
Prevalence
15%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Randomized Controlled Trial
13%
Mycobacterium Avium Complex
13%
Vasculotropin
13%
Dexamethasone
13%
Placebo
13%
Normal Human
13%
Dyspnea
12%
All Cause Mortality
12%
Disease Activity
11%
Adalimumab
11%
Metformin
11%
Recurrence Free Survival
10%
Malignant Neoplasm
10%
Combination Therapy
10%
Cause of Death
10%
Polyneuropathy
10%
Heart Failure
10%
Prospective Study
9%
Tacrolimus
9%
Biological Marker
9%
Cardiovascular Risk
8%
Small Cell Lung Cancer
8%
Metastatic Colorectal Cancer
8%
Endocrine Disease
8%
Graft Versus Host Reaction
8%
Topiroxostat
8%
SLCO1B1
8%
Sitagliptin
8%
Ipragliflozin
8%
Cross-Sectional Study
8%
Baricitinib
8%
Mucin 1
8%
Thalidomide
8%
Heart Failure with Reduced Ejection Fraction
8%
Drug Discovery
8%
Ropinirole
8%
Myasthenia gravis
8%
Thymoma
8%
Cholinergic Receptor Antibody
8%
M Protein
8%
Noninferiority Trial
8%
Lenalidomide
8%
Uric Acid
8%
Pharmacotherapy
8%
Riociguat
8%
Comparison Trial
8%
Adrenal Cortex Insufficiency
8%
Nonischemic Cardiomyopathy
8%
Adrenal Insufficiency
8%
Neuropathy
8%
Myelin Associated Glycoprotein
8%
Conjunctiva Disease
8%
Kidney Cancer
8%
Carotid Atherosclerosis
8%
Rheumatic Disease
8%
Agglutinin
8%
Amaranthus caudatus
8%
Methotrexate Polyglutamate
8%
Asthma
8%
Pancreas Adenocarcinoma
8%
Glycan
8%
Inflammatory Arthritis
8%
Keyphrases
Japan
92%
COVID-19
62%
Confidence Interval
55%
Long COVID
34%
Odds Ratio
27%
Chronic Obstructive Pulmonary Disease
27%
Brain Metastases
26%
Utopia
26%
Type 2 Diabetes Mellitus (T2DM)
26%
Multicenter Cohort Study
23%
Risk Factors
23%
Stereotactic Radiosurgery
22%
Aortic Events
21%
Japanese Patients
20%
Type 2 Diabetic Patients
20%
Nationwide Survey
18%
Propensity Score Analysis
18%
Long Coronavirus Disease
18%
Body Mass Index
18%
National Cohort Study
18%
St. George's Respiratory Questionnaire
17%
Tofogliflozin
17%
Congenital Diaphragmatic Hernia
17%
Validation Studies
17%
Graded Prognostic Assessment
17%
Lung Cancer Brain Metastases
17%
Small Cell Lung Cancer
17%
Methotrexate
17%
Asthma
17%
Rheumatoid Arthritis
17%
Type B Aortic Dissection
17%
COVID-19 Outcomes
17%
Smoking Exposure
17%
Olanexidine Gluconate
17%
Surgical Site Infection
17%
Clinical Profile
17%
Smart Eye Camera
17%
Nontuberculous Mycobacterial Lung Disease
17%
Tear Break-up Time
17%
Hazard Ratio
16%
Clinical Characteristics
16%
Dyspnea
14%
Clinical Features
14%
Uric Acid
14%
Dry Eye
13%
Age of Onset
12%
Retrospective Cohort Study
11%
Elderly Patients
11%
Clinical Parameters
11%
Adalimumab
11%
Patient Characteristics
11%
Hemoglobin
10%
Aneurysmal
10%
Polyneuropathy
10%
Serum Levels
10%
Neonate
10%
Quality of Life
10%
Health-related Quality of Life
10%
Japanese Population
9%
Infectious Diseases
9%
Pneumothorax
9%
Multivariable
9%
Psychological Distress
9%
Organ Space Surgical Site Infection
9%
Clinical Prognosis
9%
All-cause Mortality
9%
Pack-years
8%
Invasive Mechanical Ventilation
8%
Delayed Onset
8%
History of Cardiovascular Disease
8%
Liver
8%
Training Outcomes
8%
Topiroxostat
8%
Nationwide Epidemiological Survey
8%
SLCO1B1 Polymorphism
8%
COVID-19 Sequelae
8%
Sentinel Node Navigation Surgery
8%
Stump
8%
Anti-VEGF Therapy
8%
FOLFOXIRI
8%
Stage II Colorectal Cancer
8%
Stanford Type B Aortic Dissection
8%
Prospective multi-institutional Study
8%
ABO Blood Group
8%
High-risk Stage II
8%
Endocrinopathy
8%
Organomegaly
8%
Genotype
8%
Chronic Kidney Disease
8%
Nasal Pressure
8%
Baricitinib
8%
Iliac Artery Disease
8%
Left Upper Lobectomy
8%
Lower Respiratory Symptoms
8%
Acetylcholine Receptor Antibody
8%
Matched Cohort Study
8%
Myasthenia Gravis
8%
Prognostic Significance
8%
Renin-angiotensin System
8%
Skin Changes
8%